Esperion to Present at the 35th Annual J.P. Morgan Healthcare Conference
January 04, 2017 17:00 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the lipid management company focused on developing and commercializing complementary oral therapies for...